EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses

Giuseppe Ciccone, Maria Luigia Ibba, Gabriele Coppola, Silvia Catuogno iD, Carla Lucia Esposito

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24076121 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Giuseppe Ciccone und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Endocrinology and Oncology "Gaetano Salvatore" (IEOS), National Research Council (CNR), 80145 Naples, Italy. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, MicroRNAs, Aptamers, Nucleotide. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small-cell lung cancer (NSCLC) is the second most diagnosed type of malignancy and the first cause of cancer death worldwide. Despite recent advances, the treatment of choice for NSCLC patients remains to be chemotherapy, often showing very limited effectiveness with the frequent occurrence of drug-resistant phenotype and the lack of selectivity for tumor cells. Therefore, new effective and targeted therapeutics are needed. In this context, short RNA-based therapeutics, including Antisense Oligonucleotides (ASOs), microRNAs (miRNAs), short interfering (siRNA) and aptamers, represent a promising class of molecules. ASOs, miRNAs and siRNAs act by targeting and inhibiting specific mRNAs, thus showing an improved specificity compared to traditional anti-cancer drugs. Nucleic acid aptamers target and inhibit specific cancer-associated proteins, such as “nucleic acid antibodies”. Aptamers are also able of receptor-mediated cell internalization, and therefore, they can be used as carriers of secondary agents giving the possibility of producing very highly specific and effective therapeutics. This review provides an overview of the proposed applications of small RNAs for NSCLC treatment, highlighting their advantageous features and recent advancements in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMicroRNAsAptamers, NucleotideHumansRNA, Small InterferingOligonucleotidesOligonucleotides, AntisenseRNA, Messenger

Stichwörter der Autor:innen

ASONSCLCRNAiaptamertargeted therapy

Substanzen

RNA, Small InterferingOligonucleotidesOligonucleotides, AntisenseMicroRNAsRNA, MessengerAptamers, Nucleotide

Autor:innen und Institutionen

  • Institute of Experimental Endocrinology and Oncology "Gaetano Salvatore" (IEOS), National Research Council (CNR), 80145 Naples, Italy.
  • Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.
  • Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Caserta, Italy.

ORCID-Profile: Silvia Catuogno

Zitieren

APA

Ciccone, G., Ibba, M. L., Coppola, G., Catuogno, S., & Esposito, C. L. (2023). The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076121

Vancouver

Ciccone G, Ibba ML, Coppola G, Catuogno S, Esposito CL. The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076121

BibTeX
@article{Ciccone2023,
  author = {Ciccone, Giuseppe and Ibba, Maria Luigia and Coppola, Gabriele and Catuogno, Silvia and Esposito, Carla Lucia},
  title = {The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24076121}
}
Kostenlos starten →